pharma · Hyperphagia · Bariatric Surgery · AARD
Ark Therapeutics
Arkana Therapeutics is a pharma organization headquartered in Boulder, USA. It trades on NYSE under ticker AARD. Primary therapeutic focus areas include Hyperphagia, Bariatric Surgery, Obesity, Prader-Willi Syndrome, Aut
Company details
- Status
- Public
- HQ
- Boulder, USA
- Founded
- 2025
- Employees
- 4
- Programs
- 6
- Drugs
- 5
- Patents
- 7
Quick answer
Arkana Therapeutics is a pharma organization headquartered in Boulder, USA. It trades on NYSE under ticker AARD. Primary therapeutic focus areas include Hyperphagia, Bariatric Surgery, Obesity, Prader-Willi Syndrome, Autism Spectrum Disorder. NovaPharmaNews links 6 clinical program(s), 1 drug profile(s), and 7 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 2 (4), phase 3 (2).
Company snapshot
Arkana Therapeutics is developing innovative medicines for metabolic diseases by harnessing nature’s extreme biology. Arkana's approach to drug discovery leverages the natural biology of animals with extreme metabolic adaptations to uncover therapies that prevent and reverse metabolic diseases in humans. By following this evolutionarily-honed blueprint in nature, we are developing first-in-class t
- 1 approved product(s) across US/EU regulatory metadata.
- 6 active pipeline program(s) linked via ClinicalTrials.gov.
- 7 US patent(s) indexed to this assignee profile.
Public regulatory, clinical, patent, and corporate records for Ark Therapeutics. Not investment advice.
Top assets
Lead pipeline drugs
- Marketed / approved
- approved
- Marketed / approved
- Marketed / approved
Momentum
Proprietary activity score for Ark Therapeutics.
1 active signal
Signal breakdown
- Clinical trials
- Nova articles
- Patents filed
- FDA actions
- SEC filings
- Conference presentations
- Pipeline advances
Recent activity
Latest pipeline, patent, and corporate events for Ark Therapeutics.
- Clinical update
- Clinical update
- Clinical update
- Clinical update
- Clinical update
Quick answers
Common questions about this sponsor — for analysts and search.
-
What is Ark Therapeutics?
-
Is Ark Therapeutics publicly traded?
-
What drugs does Ark Therapeutics develop or market?
-
What are the latest developments for Ark Therapeutics?
-
What therapeutic areas does Ark Therapeutics focus on?
Therapeutic focus
Therapeutic area distribution
Pipeline concentration by therapeutic area from linked clinical programs.